Monograph Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,126
| Closed | -$574K | – | 126 |
|
|
2025
Q1 | $574K | Sell |
2,126
-12
| -0.6% | -$3.24K | 0.08% | 67 |
|
|
2024
Q4 | $503K | Buy |
2,138
+12
| +0.6% | +$2.82K | 0.07% | 69 |
|
|
2024
Q3 | $585K | Hold |
2,126
| – | – | 0.08% | 71 |
|
|
2024
Q2 | $517K | Hold |
2,126
| – | – | 0.08% | 66 |
|
|
2024
Q1 | $318K | Sell |
2,126
-12
| -0.6% | -$1.79K | 0.05% | 124 |
|
|
2023
Q4 | $409K | Buy |
2,138
+12
| +0.6% | +$2.3K | 0.07% | 68 |
|
|
2023
Q3 | $377K | Hold |
2,126
| – | – | 0.07% | 82 |
|
|
2023
Q2 | $404K | Hold |
2,126
| – | – | 0.09% | 57 |
|
|
2023
Q1 | $426K | Sell |
2,126
-16
| -0.7% | -$3.21K | 0.1% | 53 |
|
|
2022
Q4 | $509K | Buy |
2,142
+16
| +0.8% | +$3.8K | 0.13% | 53 |
|
|
2022
Q3 | $426K | Hold |
2,126
| – | – | 0.14% | 45 |
|
|
2022
Q2 | $310K | Sell |
2,126
-8
| -0.4% | -$1.17K | 0.09% | 58 |
|
|
2022
Q1 | $348K | Hold |
2,134
| – | – | 0.09% | 63 |
|
|
2021
Q4 | $362K | Buy |
+2,134
| New | +$362K | 0.09% | 61 |
|